Study Name: Outcomes Database to prospectivelY aSSEss changing TherapY landscape in Renal Cell Carcinoma (Odyssey)

Study Acronym: ODYSSEY-RCC

Study PI(s): Dan George

Purpose: The primary goal of this prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with metastatic renal cell carcinoma (mRCC) in routine real-world clinical practice in the United States, including both community and academic treatment settings. 

Study Sponsor: Patient-Centered Outcomes Research Institute (PCORI)

GPC Partners: 

1. 1. University of Utah (UUTAH)
   2. University of Iowa (UIOWA)
   3. University of Texas SouthWestern Medical Center (UTSWMC)
   4. Kansas University Medical Center (KUMC)
   5. Medical College of Wisconsin (MCW)